Shares Of Relypsa Hit Hard Following New Employment Inducement Grants, Confidential Treatment Order

Shares of Relypsa Inc RLYP were trading lower by nearly 4 percent at $25.78 late Wednesday morning.

Relypsa announced on Tuesday its compensation committee granted 10 new employees the option to purchase an aggregate of 34,600 shares of the company's stock at a purchase price of $27.76.

Separately, Relypsa submitted to the SEC on Wednesday an application requesting confidential treatment for information that was excluded from a 10-Q filing the company submitted on November 4, 2015.